Pandemic of atopic diseases--a lack of microbial exposure in early infancy?

M Kalliomäki, E Isolauri
{"title":"Pandemic of atopic diseases--a lack of microbial exposure in early infancy?","authors":"M Kalliomäki,&nbsp;E Isolauri","doi":"10.2174/1568005023342452","DOIUrl":null,"url":null,"abstract":"<p><p>Improved hygienic conditions in Western societies have reduced early microbial exposure, which has been proposed as a reason for the continuously rising prevalence of atopy and subsequent atopic diseases: atopic eczema, allergic rhinitis and asthma (The Hygiene Hypothesis of Allergy). This hypothesis is supported by immunological data showing that the immune response to microbial antigens, both pathogenic and non-pathogenic ones, is accompanied by preferential expression of cytokines that counterbalance the T-helper 2-polarized cytokine production of neonates, the continuity of which might lead to enhanced IgE production, atopy, and atopic disease. Experimental, epidemiological and clinical studies, conducted over the last decade, indicate that non-pathogenic microbes in the gut might be a major factor essential for the maturation of the human immune system to a nonatopic mode. A recent randomised, placebo-controlled trial demonstrated that perinatal administration of probiotics, cultures of potentially beneficial bacteria of the healthy gut microflora, halved the later development of atopic eczema during the first two years of life. Some putative mechanisms of action of gut commensals in host-microbe interactions have been described. Two structural components of bacteria, the lipopolysaccharide portion of Gram-negative bacteria and specified CpG motif in bacterial DNA, activate immunomodulatory genes via Toll-like receptors present e.g. on intestinal epithelial cells thus controlling physiological cytokine milieu in the gut. Probiotics have also been shown to reverse increased intestinal permeability and to reduce antigen load in the gut by degrading and modifying macromolecules. The actual preventive role of natural and genetically constructed supplementary microbes in the development of immunological diseases, like allergy, remains to be elucidated.</p>","PeriodicalId":84525,"journal":{"name":"Current drug targets. Infectious disorders","volume":"2 3","pages":"193-9"},"PeriodicalIF":0.0000,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"54","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug targets. Infectious disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1568005023342452","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 54

Abstract

Improved hygienic conditions in Western societies have reduced early microbial exposure, which has been proposed as a reason for the continuously rising prevalence of atopy and subsequent atopic diseases: atopic eczema, allergic rhinitis and asthma (The Hygiene Hypothesis of Allergy). This hypothesis is supported by immunological data showing that the immune response to microbial antigens, both pathogenic and non-pathogenic ones, is accompanied by preferential expression of cytokines that counterbalance the T-helper 2-polarized cytokine production of neonates, the continuity of which might lead to enhanced IgE production, atopy, and atopic disease. Experimental, epidemiological and clinical studies, conducted over the last decade, indicate that non-pathogenic microbes in the gut might be a major factor essential for the maturation of the human immune system to a nonatopic mode. A recent randomised, placebo-controlled trial demonstrated that perinatal administration of probiotics, cultures of potentially beneficial bacteria of the healthy gut microflora, halved the later development of atopic eczema during the first two years of life. Some putative mechanisms of action of gut commensals in host-microbe interactions have been described. Two structural components of bacteria, the lipopolysaccharide portion of Gram-negative bacteria and specified CpG motif in bacterial DNA, activate immunomodulatory genes via Toll-like receptors present e.g. on intestinal epithelial cells thus controlling physiological cytokine milieu in the gut. Probiotics have also been shown to reverse increased intestinal permeability and to reduce antigen load in the gut by degrading and modifying macromolecules. The actual preventive role of natural and genetically constructed supplementary microbes in the development of immunological diseases, like allergy, remains to be elucidated.

特应性疾病大流行——婴儿早期缺乏微生物接触?
西方社会卫生条件的改善减少了早期微生物暴露,这被认为是特应性和随后的特应性疾病(特应性湿疹、过敏性鼻炎和哮喘)患病率持续上升的原因之一(过敏的卫生假说)。这一假设得到了免疫学数据的支持,免疫学数据显示,对微生物抗原(病原性和非病原性)的免疫反应伴随着细胞因子的优先表达,这些细胞因子抵消了新生儿t -辅助性2极化细胞因子的产生,其连续性可能导致IgE产生增强,特应性和特应性疾病。在过去十年中进行的实验、流行病学和临床研究表明,肠道中的非致病微生物可能是人类免疫系统成熟到非特应性模式的重要因素。最近的一项随机、安慰剂对照试验表明,围产期给予益生菌(健康肠道菌群中潜在有益细菌的培养),在出生后的头两年里,将特应性湿疹的后期发展减半。一些推测的肠道共生体在宿主-微生物相互作用中的作用机制已经被描述。细菌的两种结构成分,革兰氏阴性细菌的脂多糖部分和细菌DNA中的特定CpG基序,通过存在于肠上皮细胞上的toll样受体激活免疫调节基因,从而控制肠道内的生理细胞因子环境。益生菌也被证明可以逆转增加的肠道通透性,并通过降解和修饰大分子来减少肠道内的抗原负荷。天然和遗传构建的补充微生物在过敏等免疫疾病发展中的实际预防作用仍有待阐明。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信